Literature DB >> 30900130

Association between polymorphisms of NOS1, NOS2 and NOS3 genes and suicide behavior: a systematic review and meta-analysis.

Thelma Beatriz González-Castro, Alma Delia Genis-Mendoza, Carlos Alfonso Tovilla-Zárate1, Isela Esther Juárez-Rojop2, María Lilia López-Narvaez3, Nonanzit Pérez-Hernández4, José Manuel Rodríguez-Pérez4, José Jaime Martínez-Magaña5.   

Abstract

The enzyme nitric oxide synthase has been associated with suicide behavior. NOS1, NOS2 and NOS3 genes are implicated in the production of nitric oxide. However, the association between NOS genes and suicide behavior has not yet been established. To assess the association of Nitric Oxide Synthase (NOS) genes and suicide behavior we performed a systematic review a meta-analysis. We searched articles published in three electronic databases, PubMed, Scopus and Web of Sciences, up to February 2019. We used keywords and combinations "NOS", "NOS1", "NOS2", "NOS3" and "suicide". Only articles that met the inclusion criteria were included. To assess the association between NOS genes and suicide behavior we used allelic, dominant and recessive models, as well as homozygous and heterozygous comparisons. The pooled results showed that rs2682826 of Nitric Oxide Synthase 1 gene (NOS1) increased the risk for suicide attempt in the allelic (OR: 1.34; 95 CI: 1.00-1.78), recessive (OR: 1.45; 95 CI:1.06-1.98) and heterozygous (OR: 1.41; 95 CI: 1.09-1.81) models. We found that the rs2682826 of NOS1 could increase the risk for suicide attempt. However, these results should only be taken as exploratory; more studies are necessary to determine the association between NOS genes and suicide behavior.

Entities:  

Keywords:  Biochemical markers; Biological psychiatry; NOS gene; Neuropsychiatry; Suicide

Mesh:

Substances:

Year:  2019        PMID: 30900130     DOI: 10.1007/s11011-019-00406-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

1.  Mechanisms for suppressing NADPH oxidase in the vascular wall.

Authors:  Gregory J Dusting; Stavros Selemidis; Fan Jiang
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

2.  Violent suicidal behaviour in bipolar disorder is associated with nitric oxide synthase 3 gene polymorphism.

Authors:  J Oliveira; M Debnath; B Etain; M Bennabi; N Hamdani; M Lajnef; D Bengoufa; C Fortier; W Boukouaci; F Bellivier; J-P Kahn; C Henry; D Charron; R Krishnamoorthy; M Leboyer; R Tamouza
Journal:  Acta Psychiatr Scand       Date:  2015-05-04       Impact factor: 6.392

3.  Nitric oxide interacts with monoamine oxidase to modulate aggression and anxiety-like behaviour.

Authors:  Héctor Carreño Gutiérrez; Aet O'Leary; Florian Freudenberg; Giorgio Fedele; Rob Wilkinson; Eleanor Markham; Freek van Eeden; Andreas Reif; William H J Norton
Journal:  Eur Neuropsychopharmacol       Date:  2017-09-23       Impact factor: 4.600

4.  Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1β?

Authors:  Xênia Monfrim; Marta Gazal; Pâmela B De Leon; Luciana Quevedo; Luciano D Souza; Karen Jansen; Jean P Oses; Ricardo T Pinheiro; Ricardo A Silva; Diogo R Lara; Gabriele Ghisleni; Barbara Spessato; Manuella P Kaster
Journal:  Bipolar Disord       Date:  2014-05-26       Impact factor: 6.744

5.  A case-control association study of 12 candidate genes and attempted suicide in French adolescents.

Authors:  Bojan Mirkovic; David Cohen; Claudine Laurent; Malaika Lasfar; Christophe Marguet; Prsicille Gerardin
Journal:  Int J Adolesc Med Health       Date:  2017-09-13

6.  Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience.

Authors:  Dagmar Bruenig; Charles P Morris; Divya Mehta; Wendy Harvey; Bruce Lawford; Ross McD Young; Joanne Voisey
Journal:  Gene       Date:  2017-04-29       Impact factor: 3.688

Review 7.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

8.  NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.

Authors:  Dan Rujescu; Ina Giegling; Laura Mandelli; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Hans-Jürgen Möller; Alessandro Serretti
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-01-05       Impact factor: 3.568

9.  High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex.

Authors:  J K Lauridsen; R H Olesen; J Vendelbo; T M Hyde; J E Kleinman; B M Bibby; B Brock; J Rungby; A Larsen
Journal:  Transl Psychiatry       Date:  2017-02-28       Impact factor: 6.222

Review 10.  Nitric Oxide-Mediated Posttranslational Modifications: Impacts at the Synapse.

Authors:  Sophie A Bradley; Joern R Steinert
Journal:  Oxid Med Cell Longev       Date:  2015-11-09       Impact factor: 6.543

View more
  3 in total

Review 1.  Prospects for the Personalized Multimodal Therapy Approach to Pain Management via Action on NO and NOS.

Authors:  Natalia A Shnayder; Marina M Petrova; Tatiana E Popova; Tatiana K Davidova; Olga P Bobrova; Vera V Trefilova; Polina S Goncharova; Olga V Balberova; Kirill V Petrov; Oksana A Gavrilyuk; Irina A Soloveva; German V Medvedev; Regina F Nasyrova
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

2.  Temporal patterns of suicide and circulatory system disease-related mortality are inversely correlated in several countries.

Authors:  Marc J Kaufman; Garrett M Fitzmaurice
Journal:  BMC Psychiatry       Date:  2021-03-16       Impact factor: 3.630

3.  Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods.

Authors:  Alena A Kozlova; Anastasia N Vaganova; Roman N Rodionov; Raul R Gainetdinov; Nadine Bernhardt
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.